CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

被引:128
|
作者
Lineburg, Katie E. [1 ,2 ]
Grant, Emma J. [3 ,4 ]
Swaminathan, Srividhya [1 ,2 ,5 ]
Chatzileontiadou, Demetra S. M. [3 ,4 ]
Szeto, Christopher [3 ,4 ]
Sloane, Hannah [3 ,4 ]
Panikkar, Archana [1 ,2 ]
Raju, Jyothy [1 ,2 ]
Crooks, Pauline [1 ,2 ]
Rehan, Sweera [1 ,2 ]
Nguyen, Andrea T. [3 ,4 ]
Lekieffre, Lea [1 ,2 ]
Neller, Michelle A. [1 ,2 ]
Tong, Zhen Wei Marcus [6 ]
Jayasinghe, Dhilshan [3 ,4 ]
Chew, Keng Yih [6 ]
Lobos, Christian A. [3 ,4 ]
Halim, Hanim [3 ]
Burrows, Jacqueline M. [1 ,2 ]
Riboldi-Tunnicliffe, Alan [7 ]
Chen, Weisan [4 ]
D'Orsogna, Lloyd [8 ,9 ]
Khanna, Rajiv [1 ,2 ]
Short, Kirsty R. [6 ,10 ]
Smith, Corey [1 ,2 ,5 ]
Gras, Stephanie [3 ,4 ]
机构
[1] QIMR Berghofer Med Res Inst, QIMR Berghofer Ctr Immunotherapy & Vaccine Dev, Dept Immunol, Brisbane, Qld 4006, Australia
[2] QIMR Berghofer Med Res Inst, Translat & Human Immunol Lab, Dept Immunol, Brisbane, Qld 4006, Australia
[3] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[4] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia
[5] Univ Queensland, Fac Med, Brisbane, Qld 4072, Australia
[6] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia
[7] ANSTO, Australian Synchrotron, Clayton, Vic 3168, Australia
[8] Fiona Stanley Hosp, Dept Clin Immunol, PathWest Lab Med, Murdoch, WA 6150, Australia
[9] Univ Western Australia, Sch Med, Nedlands, WA 6009, Australia
[10] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
COVID-19; IMMUNITY; ESCAPE; IMPACT; TCR;
D O I
10.1016/j.immuni.2021.04.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Efforts are beingmade worldwide to understand the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, including the impact of T cell immunity and cross-recognition with seasonal coronaviruses. Screening of SARS-CoV-2 peptide pools revealed that the nucleocapsid (N) protein induced an immunodominant response in HLA-B7(+) COVID-19-recovered individuals that was also detectable in unexposed donors. A single N-encoded epitope that was highly conserved across circulating coronaviruses drove this immunodominant response. In vitro peptide stimulation and crystal structure analyses revealed T cell-mediated cross-reactivity toward circulating OC43 and HKU-1 betacoronaviruses but not 229E or NL63 alphacoronaviruses because of different peptide conformations. T cell receptor (TCR) sequencing indicated that cross-reactivity was driven by private TCR repertoires with a bias for TRBV27 and a long CDR3b loop. Our findings demonstrate the basis of selective T cell cross-reactivity for an immunodominant SARS-CoV-2 epitope and its homologs from seasonal coronaviruses, suggesting long-lasting protective immunity.
引用
收藏
页码:1055 / +
页数:16
相关论文
共 50 条
  • [31] SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients
    Saini, Sunil Kumar
    Hersby, Ditte Stampe
    Tamhane, Tripti
    Povlsen, Helle Rus
    Hernandez, Susana Patricia Amaya
    Nielsen, Morten
    Gang, Anne Ortved
    Hadrup, Sine Reker
    SCIENCE IMMUNOLOGY, 2021, 6 (58)
  • [32] CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques
    Liu, Jinyan
    Yu, Jingyou
    McMahan, Katherine
    Jacob-Dolan, Catherine
    He, Xuan
    Giffin, Victoria
    Wu, Cindy
    Sciacca, Michaela
    Powers, Olivia
    Nampanya, Felix
    Miller, Jessica
    Lifton, Michelle
    Hope, David
    Hall, Kevin
    Hachmann, Nicole P.
    Chung, Benjamin
    Anioke, Tochi
    Li, Wenjun
    Muench, Jeanne
    Gamblin, Adrienne
    Boursiquot, Mona
    Cook, Anthony
    Lewis, Mark G.
    Andersen, Hanne
    Barouch, Dan H.
    SCIENCE IMMUNOLOGY, 2022, 7 (77)
  • [33] Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients
    Taus, Ellie
    Shino, Michael Y.
    Ibarrondo, F. Javier
    Hausner, Mary Ann
    Hofmann, Christian
    Yang, Otto O.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [34] Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
    Dykema, Arbor G.
    Zhang, Boyang
    Woldemeskel, Bezawit A.
    Garliss, Caroline C.
    Cheung, Laurene S.
    Choudhury, Dilshad
    Zhang, Jiajia
    Aparicio, Luis
    Bom, Sadhana
    Rashid, Rufiaat
    Caushi, Justina X.
    Hsiue, Emily Han-Chung
    Cascino, Katherine
    Thompson, Elizabeth A.
    Kwaa, Abena K.
    Singh, Dipika
    Thapa, Sampriti
    Ordonez, Alvaro A.
    Pekosz, Andrew
    D'Alessio, Franco R.
    Powell, Jonathan D.
    Yegnasubramanian, Srinivasan
    Zhou, Shibin
    Pardoll, Drew M.
    Ji, Hongkai
    Cox, Andrea L.
    Blankson, Joel N.
    Smith, Kellie N.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (10)
  • [35] Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
    Ying, Baoling
    Darling, Tamarand L.
    Desai, Pritesh
    Liang, Chieh-Yu
    Dmitriev, Igor P.
    Soudani, Nadia
    Bricker, Traci
    Kashentseva, Elena A.
    Harastani, Houda
    Raju, Saravanan
    Liu, Meizi
    Schmidt, Aaron G.
    Curiel, David T.
    Boon, Adrianus C. M.
    Diamond, Michael S.
    NATURE IMMUNOLOGY, 2024, 25 (3) : 537 - 551
  • [36] Structural basis for SARS-CoV-2 spike CD4+T-cell Epitope dominance
    Landry, Samuel J.
    Mettu, Ramgopal R.
    Steede, N. Kalaya
    Norton, Elizabeth
    Aberle, Judith H.
    Gunn, Bronwyn
    Shaffer, Jeffrey
    Zheng, Crystal
    Robinson, James E.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 : 9 - 10
  • [37] The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
    de Silva, Thushan, I
    Liu, Guihai
    Lindsey, Benjamin B.
    Dong, Danning
    Moore, Shona C.
    Hsu, Nienyun Sharon
    Shah, Dhruv
    Wellington, Dannielle
    Mentzer, Alexander J.
    Angyal, Adrienn
    Brown, Rebecca
    Parker, Matthew D.
    Ying, Zixi
    Yao, Xuan
    Turtle, Lance
    Dunachie, Susanna
    Maini, Mala K.
    Ogg, Graham
    Knight, Julian C.
    Peng, Yanchun
    Rowland-Jones, Sarah L.
    Dong, Tao
    ISCIENCE, 2021, 24 (11)
  • [38] Blood CD8+ Naive T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine
    Rodero-Romero, Alexander
    de la Maza, Susana Sainz
    Fernandez-Velasco, Jose Ignacio
    Monreal, Enric
    Walo-Delgado, Paulette Esperanza
    Chico-Garcia, Juan Luis
    Villarrubia, Noelia
    Rodriguez-Jorge, Fernando
    Rodriguez-Ramos, Rafael
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Villar, Luisa Maria
    VACCINES, 2023, 11 (09)
  • [39] The molecular mechanisms of CD8+ T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions
    Deng, Shasha
    Xu, Zhihao
    Hu, Jing
    Yang, Yunru
    Zhu, Fang
    Liu, Zhuan
    Zhang, Hongliang
    Wu, Songquan
    Jin, Tengchuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19
    Ford, Emily S.
    Mayer-Blackwell, Koshlan
    Jing, Lichen
    Laing, Kerry J.
    Sholukh, Anton M.
    Germain, Russell St.
    Bossard, Emily L.
    Xie, Hong
    Pulliam, Thomas H.
    Jani, Saumya
    Selke, Stacy
    Burrow, Carlissa J.
    McClurkan, Christopher L.
    Wald, Anna
    Greninger, Alexander L.
    Holbrook, Michael R.
    Eaton, Brett
    Eudy, Elizabeth
    Murphy, Michael
    Postnikova, Elena
    Robins, Harlan S.
    Elyanow, Rebecca
    Gittelman, Rachel M.
    Ecsedi, Matyas
    Wilcox, Elise
    Chapuis, Aude G.
    Fiore-Gartland, Andrew
    Koelle, David M.
    NATURE IMMUNOLOGY, 2024, 25 (01) : 166 - 177